Psychotropic Agents: Synthesis and Antipsychotic Activity of Substituted β-Carbolines

Journal of Medicinal Chemistry

Volumn 30, Issue 6, 1987, Pages 1100-1105

  Abou Gharbia, Magid ^a   Patel, Usha R ^a   Moyer, John A ^a   Muth, Eric A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIORITY JOURNAL;

ANIMAL; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; CARBOLINES; MALE; MICE; RATS; STEREOTYPED BEHAVIOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0023215435     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00389a022     Document Type: Article

References (23)

1. Matthysse, S.; Fed. Proc., Fed. Am. Soc. Exp. Biol. 1973, 32, 200.
2. Snyder, S. H.; Banerjee, S. P.; Yamamura, H. I.; Greenberg, D.; Science (Washington, D. C.) 1974, 184, 1243.
3. Snyder, S. H.; Am. J. Psychiatry 1981, 138, 460.
4. Crow, T.; J. Trends NeuroSci. 1982, 6, 351.
5. Grohnmann, R.; Gunther, W.; Ruther, E.; Psychopharmacology, Part 2, Clinical Psychopharmacology; Hippius, H., Winokur, G., Eds.; Excerta Medica: Amsterdam, 1983; Chapter 27.
6. Vinick, F. J.; Kozolowski, M. R.; Annual Reports in Medicinal Chemistry; Hesp, B., Ed.; Academic: Orlando, FL, 1986; Vol. 21, Chapter 1.
7. Aden, N. E.; J. Psychiat. Res. 1974, 11, 97.
8. Ferris, R. M.; Harfenist, M.; McKenzie, G. A.; Cooper, B.; Soroko, F. E.; Maxwell, R. A.; J. Pharm. Pharmacol. 1982, 34, 388–390.
9. Robertson, A.; MacDonald, C.; Pharmacol. Biochem. Behav. 1986, 24, 163.
10. Fielding, S.; Novick, W. J., Jr.; Geyer, H. M.; Petko, W. W.; Wilker, J. C.; Davis, L.; Klein, J. T.; Cornfeldt, M. Drug Dev. Res. 1983, 3, 233.
11. Niemergeers, C. S. E.; Neuroleptics; Fieldings, S., Lai, H., Eds.; Futuro: Mt. Kosco, NY, 1974; Pp 98–129.
12. Schwarcz, G.; Halaris, A.; Dern, A.; Manberg, P.; Drug. Dev. Res. 1985, 5.,387.
13. Davidson, J.; Miller, R.; Wingfield, M.; Zung, W.; Dern, A.; T. Psychopharmacol. Bull. 1982, 18, 173.
14. Kanaoka, Y.; Sato, E.; Yoshio, B. Chem. Pharm, Bull. 1967, 15, 191.
15. Yevich, J. P.; Temple, D. L., Jr.; New, J. S.; Taylor, D. P.; Riblet, C. A. J. Med. Chem. 1983, 26, 194–203.
16. Mioque, M.; Gautier, A. J. C. R. Hebd. Seances Acad. Sci. 1961, 252, 2416.
17. Herman, R. L.; Malick, J. B.; Kubena, R. K.; Psychopharmacol. Commun. 1979, 3, 165–171.
18. Fields, J. E.; Reisine, T. D.; Yamamura, H. I.; Brain Res. 1977, 136, 578.
19. Bennett, J. P.; In Neurotransmitter RecePtor Binding; Yamamura, H. I., Enna, S., Kuhar, M. J., Eds.; Raven: New York, 1978; P 57.
20. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J.; J. Biol. Chem. 1951, 193, 265.
21. Cheng, Y. C.; Prusoff, W. H.; Biochem. Pharmacol. 1973, 22, 3099.
22. Ferris, R. M.; Harfenist, M.; McKenzie, G. M.; Cooper, B.; Soroko, F. E.; Maxwell, R. A.; J. Pharm. Pharrnacol. 1982, 34, 388.
23. Snyder, S. H.; Creese, I.; Burt, D.R.; Psychopharmacol. Commun. 1975, 1, 663.